Yi‐Fang Chang

NKG2A Down-Regulation by Dasatinib Enhances Natural Killer Cytotoxicity and Accelerates Effective Treatment Responses in Patients With Chronic Myeloid Leukemia

Ming‐Chin Chang, Hung-I Cheng, Kate Hsu et al. · Frontiers in Immunology · 2019 · 50 citations · Full text

Medicine, Oncology, Pharmacology +17

BAFF-driven NLRP3 inflammasome activation in B cells

Ken‐Hong Lim, Lih‐Chyang Chen, Kate Hsu et al. · Cell Death and Disease · 2020 · 49 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Targeted next-generation sequencing identified novel mutations in triple-negative myeloproliferative neoplasms

Yu‐Cheng Chang, Huan‐Chau Lin, Yi‐Hao Chiang et al. · Medical Oncology · 2017 · 48 citations

Medicine, Genetics, Hematology +13

Immune impairment in patients with terminal cancers: influence of cancer treatments and cytomegalovirus infection

I-Hsuan Chen, Yuen‐Liang Lai, Chien‐Liang Wu et al. · Cancer Immunology Immunotherapy · 2009 · 41 citations · Full text

Medicine, Immunology, Oncology +17

Epidermal growth factor induces STAT1 expression to exacerbate the IFNr‐mediated PD‐L1 axis in epidermal growth factor receptor‐positive cancers

Chun‐Chia Cheng, Hsin‐Chi Lin, Kaun‐Jer Tsai et al. · Molecular Carcinogenesis · 2018 · 41 citations

Medicine, Molecular Biology, Oncology +17